The present study’s novelty is applying the sensitivity of thyroid hormone indices rather than absolute circulating values of FT3 and FT4 as a predictor of NAFLD risk, which could provide more information on the association between thyroid hormone resistance and NAFLD. The gene discussed is TG; the disease is metabolic dysfunction-associated steatotic liver disease.